The influence of increasing age on the deliverability and toxicity of fludarabine-based combination chemotherapy regimens in patients with indolent lymphoproliferative disorders
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference56 articles.
1. Cancer Surveillance Series: Non-Hodgkin's Lymphoma Incidence by Histologic Subtype in the United States From 1978 Through 1995
2. Changing incidence of non-Hodgkin lymphomas in the United States
3. Trends in leukemia incidence and survival in the United States (1973–1998)
4. Leukemias, myeloma, and other lymphoreticular neoplasms
5. Chronic lymphocytic leukaemia at a county hospital in southern Sweden
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Safety and Efficacy of Bendamustine and Rituximab (BR) Regimen in Indian Chronic Lymphocytic Leukaemia Patients;Indian Journal of Hematology and Blood Transfusion;2022-05-27
2. Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy;Leukemia & Lymphoma;2015-11-20
3. How applicable is fludarabine, cyclophosphamide and rituximab to the elderly?;Leukemia & Lymphoma;2014-11-20
4. De novoB-cell prolymphocytic leukemia with central nervous system involvement;Leukemia & Lymphoma;2014-04-29
5. Fludarabine: A review of the clear benefits and potential harms;Leukemia Research;2013-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3